Treatment with the MAO-A inhibitor clorgyline elevates monoamine neurotransmitter levels and improves affective phenotypes in a mouse model of Huntington disease

10.1016/j.expneurol.2016.01.019

Saved in:
Bibliographic Details
Main Authors: Garcia-Miralles, Marta, Ooi, Jolene, Bardile, Costanza Ferrari, Tan, Liang Juin, George, Maya, Drum, Chester L, Lin, Rachel Yanping, Hayden, Michael R, Pouladi, Mahmoud A
Other Authors: DEAN'S OFFICE (MEDICINE)
Format: Article
Language:English
Published: ACADEMIC PRESS INC ELSEVIER SCIENCE 2022
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/234700
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Language: English
id sg-nus-scholar.10635-234700
record_format dspace
spelling sg-nus-scholar.10635-2347002024-11-15T08:53:19Z Treatment with the MAO-A inhibitor clorgyline elevates monoamine neurotransmitter levels and improves affective phenotypes in a mouse model of Huntington disease Garcia-Miralles, Marta Ooi, Jolene Bardile, Costanza Ferrari Tan, Liang Juin George, Maya Drum, Chester L Lin, Rachel Yanping Hayden, Michael R Pouladi, Mahmoud A DEAN'S OFFICE (MEDICINE) MEDICINE Dr Chester Lee Drum Science & Technology Life Sciences & Biomedicine Neurosciences Neurosciences & Neurology Huntington's disease Monoamine oxidase Monoamine oxidase inhibitors Mouse model Psychiatric features Depression Anxiety Monoamines HIPPOCAMPAL NEUROGENESIS GENE CARRIERS OXIDASE DEPRESSION DYSFUNCTION BEHAVIOR ANXIETY LITHIUM MICE PATHOGENESIS 10.1016/j.expneurol.2016.01.019 EXPERIMENTAL NEUROLOGY 278 4-10 2022-11-18T05:01:05Z 2022-11-18T05:01:05Z 2016-04-01 2022-11-18T02:38:06Z Article Garcia-Miralles, Marta, Ooi, Jolene, Bardile, Costanza Ferrari, Tan, Liang Juin, George, Maya, Drum, Chester L, Lin, Rachel Yanping, Hayden, Michael R, Pouladi, Mahmoud A (2016-04-01). Treatment with the MAO-A inhibitor clorgyline elevates monoamine neurotransmitter levels and improves affective phenotypes in a mouse model of Huntington disease. EXPERIMENTAL NEUROLOGY 278 : 4-10. ScholarBank@NUS Repository. https://doi.org/10.1016/j.expneurol.2016.01.019 00144886 10902430 https://scholarbank.nus.edu.sg/handle/10635/234700 en ACADEMIC PRESS INC ELSEVIER SCIENCE Elements
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
language English
topic Science & Technology
Life Sciences & Biomedicine
Neurosciences
Neurosciences & Neurology
Huntington's disease
Monoamine oxidase
Monoamine oxidase inhibitors
Mouse model
Psychiatric features
Depression
Anxiety
Monoamines
HIPPOCAMPAL NEUROGENESIS
GENE CARRIERS
OXIDASE
DEPRESSION
DYSFUNCTION
BEHAVIOR
ANXIETY
LITHIUM
MICE
PATHOGENESIS
spellingShingle Science & Technology
Life Sciences & Biomedicine
Neurosciences
Neurosciences & Neurology
Huntington's disease
Monoamine oxidase
Monoamine oxidase inhibitors
Mouse model
Psychiatric features
Depression
Anxiety
Monoamines
HIPPOCAMPAL NEUROGENESIS
GENE CARRIERS
OXIDASE
DEPRESSION
DYSFUNCTION
BEHAVIOR
ANXIETY
LITHIUM
MICE
PATHOGENESIS
Garcia-Miralles, Marta
Ooi, Jolene
Bardile, Costanza Ferrari
Tan, Liang Juin
George, Maya
Drum, Chester L
Lin, Rachel Yanping
Hayden, Michael R
Pouladi, Mahmoud A
Treatment with the MAO-A inhibitor clorgyline elevates monoamine neurotransmitter levels and improves affective phenotypes in a mouse model of Huntington disease
description 10.1016/j.expneurol.2016.01.019
author2 DEAN'S OFFICE (MEDICINE)
author_facet DEAN'S OFFICE (MEDICINE)
Garcia-Miralles, Marta
Ooi, Jolene
Bardile, Costanza Ferrari
Tan, Liang Juin
George, Maya
Drum, Chester L
Lin, Rachel Yanping
Hayden, Michael R
Pouladi, Mahmoud A
format Article
author Garcia-Miralles, Marta
Ooi, Jolene
Bardile, Costanza Ferrari
Tan, Liang Juin
George, Maya
Drum, Chester L
Lin, Rachel Yanping
Hayden, Michael R
Pouladi, Mahmoud A
author_sort Garcia-Miralles, Marta
title Treatment with the MAO-A inhibitor clorgyline elevates monoamine neurotransmitter levels and improves affective phenotypes in a mouse model of Huntington disease
title_short Treatment with the MAO-A inhibitor clorgyline elevates monoamine neurotransmitter levels and improves affective phenotypes in a mouse model of Huntington disease
title_full Treatment with the MAO-A inhibitor clorgyline elevates monoamine neurotransmitter levels and improves affective phenotypes in a mouse model of Huntington disease
title_fullStr Treatment with the MAO-A inhibitor clorgyline elevates monoamine neurotransmitter levels and improves affective phenotypes in a mouse model of Huntington disease
title_full_unstemmed Treatment with the MAO-A inhibitor clorgyline elevates monoamine neurotransmitter levels and improves affective phenotypes in a mouse model of Huntington disease
title_sort treatment with the mao-a inhibitor clorgyline elevates monoamine neurotransmitter levels and improves affective phenotypes in a mouse model of huntington disease
publisher ACADEMIC PRESS INC ELSEVIER SCIENCE
publishDate 2022
url https://scholarbank.nus.edu.sg/handle/10635/234700
_version_ 1821230218281484288